The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Is the Framingham risk function valid for northern European populations? A comparison of methods for estimating absolute coronary risk in high risk men
Open accessAbstract
Objective: To examine the validity of estimates of coronary heart disease (CHD) risk by the Framingham risk function, for European populations. Design: Comparison of CHD risk estimates for individuals derived from the Framingham, prospective cardiovascular Münster (PROCAM), Dundee, and British regional heart (BRHS) risk functions. Setting: Sheffield Hypertension Clinic. Patients—206 consecutive hypertensive men aged 35–75 years without preexisting vascular disease. Results: There was close agreement among the Framingham, PROCAM, and Dundee risk functions for average CHD risk. For individuals the best correlation was between Framingham and PROCAM, both of which use high density lipoprotein (HDL) cholesterol. When Framingham was used to target a CHD event rate > 3% per year, it identified men with mean CHD risk by PROCAM of 4.6% per year and all had CHD event risks > 1.5% per year. Men at lower risk by Framingham had a mean CHD risk by PROCAM of 1.5% per year, with 16% having a CHD event risk > 3.0% per year. BRHS risk function estimates of CHD risk were fourfold lower than those for the other three risk functions, but with moderate correlations, suggesting an important systematic error. Conclusion: There is close agreement between the Framingham, PROCAM, and Dundee risk functions as regards average CHD risk, and moderate agreement for estimates within individuals. Taking PROCAM as the external standard, the Framingham function separates high and low CHD risk groups and is acceptably accurate for northern European populations, at least in men.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENT
Martin Bland, J., & Altman, D. (1986) · The Lancet · doi:10.1016/s0140-6736(86)90837-8 · Cited by 47,965
Prevention of Coronary Heart Disease with Pravastatin in Men with Hypercholesterolemia
Shepherd, J., Cobbe, S. M., Ford, I., Isles, C. G., Lorimer, A. R., Macfarlane, P. W., McKillop, J. H., & Packard, C. J. (1995) · New England Journal of Medicine · doi:10.1056/nejm199511163332001 · Cited by 7,449 · cited 1×
“Accepting that there will be some error in CHD risk estimation, one would wish that those targeted for statin treatment would have a CHD event rate of at least 1.5% per year, the lower “boundary” for proven clinical efficacy derived from the WOSCOPS trial.”
BackgroundInfluentialStatistical methods for assessing agreement between two methods of clinical measurement
Bland, J. M., & Altman, D. G. (2010) · International Journal of Nursing Studies · doi:10.1016/j.ijnurstu.2009.10.001 · Cited by 5,220
The number needed to treat: a clinically useful measure of treatment effect
Cook, R. J., & Sackett, D. L. (1995) · BMJ · doi:10.1136/bmj.310.6977.452 · Cited by 1,885
Cited by
Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project
Conroy, R. (2003) · European Heart Journal · doi:10.1016/s0195-668x(03)00114-3 · Cited by 5,290
Mancia, G., Kreutz, R., Brunström, M., Burnier, M., Grassi, G., Januszewicz, A., Muiesan, M. L., Tsioufis, K., Agabiti-Rosei, E., Algharably, E. A. E., et al. (2023) · Journal of Hypertension · doi:10.1097/hjh.0000000000003480 · Cited by 3,473
Authors/Task Force Members, Ryden, L., Standl, E., Bartnik, M., Van den Berghe, G., Betteridge, J., de Boer, M.-J., Cosentino, F., Jonsson, B., Laakso, M., et al. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehl260 · Cited by 1,647
Williams, B., Poulter, N. R., Brown, M. J., Davis, M., McInnes, G. T., Potter, J. F., Sever, P. S., & McG Thom, S. (2004) · Journal of Human Hypertension · doi:10.1038/sj.jhh.1001683 · Cited by 1,272
Kivipelto, M., Ngandu, T., Laatikainen, T., Winblad, B., Soininen, H., & Tuomilehto, J. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70537-3 · Cited by 1,126
Hypertension Treatment and Control in Five European Countries, Canada, and the United States
Wolf-Maier, K., Cooper, R. S., Kramer, H., Banegas, J. R., Giampaoli, S., Joffres, M. R., Poulter, N., Primatesta, P., Stegmayr, B., & Thamm, M. (2004) · Hypertension · doi:10.1161/01.hyp.0000103630.72812.10 · Cited by 1,083
Panagiotakos, D. B., Pitsavos, C., Arvaniti, F., & Stefanadis, C. (2007) · Preventive Medicine · doi:10.1016/j.ypmed.2006.12.009 · Cited by 637
A systematic review and economic evaluation of statins for the prevention of coronary events
Ward, S., Lloyd Jones, M., Pandor, A., Holmes, M., Ara, R., Ryan, A., Yeo, W., & Payne, N. (2007) · Health Technology Assessment · doi:10.3310/hta11140 · Cited by 556
Self-citationPredictive accuracy of the Framingham coronary risk score in British men:prospective cohort study
Brindle, P., Jonathan, E., Lampe, F., Walker, M., Whincup, P., Fahey, T., & Ebrahim, S. (2003) · BMJ · doi:10.1136/bmj.327.7426.1267 · Cited by 525
Estimación del riesgo coronario en España mediante la ecuación de Framingham calibrada
Marrugat, J., Solanas, P., D’Agostino, R., Sullivan, L., Ordovas, J., Cordón, F., Ramos, R., Sala, J., Masià, R., Rohlfs, I., et al. (2003) · Revista Española de Cardiología · doi:10.1016/s0300-8932(03)76861-4 · Cited by 460
Augmentation index is associated with cardiovascular risk
Nürnberger, J., Keflioglu-Scheiber, A., Opazo Saez, A. M., Wenzel, R. R., Philipp, T., & Schäfers, R. F. (2002) · Journal of Hypertension · doi:10.1097/00004872-200212000-00020 · Cited by 440
Hense, H. (2003) · European Heart Journal · doi:10.1016/s0195-668x(03)00081-2 · Cited by 372
Pitsavos, C., Panagiotakos, D. B., Chrysohoou, C., & Stefanadis, C. (2003) · BMC Public Health · doi:10.1186/1471-2458-3-32 · Cited by 350
Improved Hypertension Management and Control: Results From the Health Survey for England 1998
Primatesta, P., Brookes, M., & Poulter, N. R. (2001) · Hypertension · doi:10.1161/hyp.38.4.827 · Cited by 276
IJzerman, R. G., De Jongh, R. T., Beijk, M. A. M., Van Weissenbruch, M. M., Delemarre‐van de Waal, H. A., Serné, E. H., & Stehouwer, C. D. A. (2003) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2003.01179.x · Cited by 273
Empana, J. (2003) · European Heart Journal · doi:10.1016/j.ehj.2003.09.002 · Cited by 263
Aktas, M. K. (2004) · JAMA · doi:10.1001/jama.292.12.1462 · Cited by 193
Barriers to implementing cardiovascular risk tables in routine general practice
Steenkiste, B. V., Weijden, T. V. D., Stoffers, H. E. J. H., & Grol, R. (2004) · Scandinavian Journal of Primary Health Care · doi:10.1080/02813430310004489 · Cited by 104
“The cardiovascular risks in these tables are mostly derived from Framingham data (1,2).”
Matsumoto, M., Ishikawa, S., Kayaba, K., Gotoh, T., Nago, N., Tsutsumi, A., & Kajii, E. (2009) · Journal of Epidemiology · doi:10.2188/jea.je20080081 · Cited by 23
Metadata
- Authors
- Haq, I. U., Ramsay, L. E., Yeo, W. W., Jackson, P. R., & Wallis, E. J.
- Venue
- Heart
- Publisher
- BMJ
- Published
- 1999-01-01
- Volume
- 81
- Issue
- 1
- Pages
- 40-46
- ISSN
- 1355-6037 (ISSN-L)
- 1468-201X
- OpenAlex
- W2142662148
- Cited by
- 215
- References
- 4
- FWCI
- 23.53
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.